Deregulated miRNAs in Hereditary Breast Cancer Revealed a Role for miR-30c in Regulating KRAS Oncogene

miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors

(2011) Espen Enerly et al.   PLoS One

MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer

(2010) F. Germán Rodríguez-González et al.   BREAST CANCER RESEARCH AND TREATMENT

The role of MAP kinases and MAP kinase phosphatase-1 in resistance to breast cancer treatment

(2010) Kelly K. Haagenson et al.   CANCER AND METASTASIS REVIEWS

miRNA-96 Suppresses KRAS and Functions as a Tumor Suppressor Gene in Pancreatic Cancer

(2010) S. Yu et al.   CANCER RESEARCH

Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway

(2010) O. A. Kent et al.   GENES & DEVELOPMENT

Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells

(2010) F Yu et al.   ONCOGENE

MicroRNAs and Cancer: Short RNAs Go a Long Way

(2009) Andrea Ventura et al.   CELL

Pomelo II: finding differentially expressed genes

(2009) E. R. Morrissey et al.   NUCLEIC ACIDS RESEARCH

Role of miR-143 targeting KRAS in colorectal tumorigenesis

(2009) X Chen et al.   ONCOGENE

MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary

(2009) Cheng-Han Lee et al.   PLoS One

Mitotic catastrophe cell death induced by heat shock protein 90 inhibitor in BRCA1-deficient breast cancer cell lines

(2008) M. Zajac et al.   MOLECULAR CANCER THERAPEUTICS

The Molecular Pathology of Hereditary Breast Cancer

(2008) J. Palacios et al.   PATHOBIOLOGY